BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31607703)

  • 1. Utility of
    Verma A; Menon S; Rekhi B; Pai T; Maheshwari A; Ghosh J; Gupta S; Deodhar K
    Indian J Cancer; 2019; 56(4):335-340. PubMed ID: 31607703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
    Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
    Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
    Alkanat NE; Uner A; Usubutun A
    Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
    [No Abstract]   [Full Text] [Related]  

  • 5. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.
    Kruse AJ; Croce S; Kruitwagen RF; Riedl RG; Slangen BF; Van Gorp T; Van de Vijver KK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1616-22. PubMed ID: 25244606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L; Zhao W; Zhao Z; Zhu Y
    Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
    Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
    Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
    Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
    J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
    Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
    Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
    Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
    Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.
    Lee CH; Hoang LN; Yip S; Reyes C; Marino-Enriquez A; Eilers G; Tao D; Chiang S; Fletcher JA; Soslow RA; Nucci MR; Oliva E
    Mod Pathol; 2014 May; 27(5):751-7. PubMed ID: 24186140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
    Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
    Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.
    Stewart CJ; Leung YC; Murch A; Peverall J
    Histopathology; 2014 Oct; 65(4):473-82. PubMed ID: 24592973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
    Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.
    Hemming ML; Wagner AJ; Nucci MR; Chiang S; Wang L; Hensley ML; George S
    Gynecol Oncol; 2017 Jun; 145(3):531-535. PubMed ID: 28390819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.